![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Elysee Development Corp (PK) | USOTC:ASXSF | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.04154 | 21.12% | 0.23824 | 0.193 | 0.3345 | 0.23824 | 0.23824 | 0.23824 | 1,106 | 21:00:35 |
Conference Call Information:
Date: Wednesday, February 15, 2012 Time: 10:00 am ET Toll Free: 888-378-4361 Toll: 719-325-2286 Passcode: 4519320
Replay Information:
Please dial in at least 10 minutes prior to the call to ensure timely participation. A replay of the call will be available through March 15, 2012.To listen, please call 888-203-1112 for toll free or 719-457-0820. Utilize the pass code 4519320 for the replay.
Additionally, a live and archived version of the earnings call will be available at www.remedent.com. Please access the website approximately 10 minutes prior to the start time in order to download and install any necessary software.
About Remedent
Remedent, Inc. specializes in the research, development and manufacturing and the marketing of oral care and cosmetic dental products. The Company serves the professional dental industry with breakthrough technology for dental veneers. These products are supported by a line of professional veneer whitening and tooth sensitivity solutions. Headquartered in Belgium, Remedent distributes its products to more than 55 countries in the worldwide. For more information, go to www.remedent.com.
Forward-Looking Statements
Statements in this press release that are "forward-looking statements" are based on current expectations and assumptions that are subject to risks and uncertainties. Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause Remedent's actual operating results to be materially different from any historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements that explicitly describe these risks and uncertainties, readers are urged to consider statements that contain terms such as "believes," "belief," "expects," "expect," "intends," "intend," "anticipate," "anticipates," "plans," "plan," "projects," "project," to be uncertain and forward-looking. Actual results could differ materially because of factors such as Remedent's ability to achieve the synergies and value creation contemplated by the proposed transaction. For further information regarding risks and uncertainties associated with Remedent's business, please refer to the risk factors described in Remedent's filings with the Securities and Exchange Commission, including, but not limited to, its annual report on Form 10-K and quarterly reports on Form 10-Q. We undertake no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this press release.
For more information, please contact: Company Remedent, Inc. Stephen Ross CFO Phone: +1-310-922-5685 E-mail: docktor99@aol.com Investor Relations MZ Group Scott Powell Senior Vice President Phone: +1-212-301-7130 E-mail: scott.powell@hcinternational.net
1 Year Elysee Development (PK) Chart |
1 Month Elysee Development (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions